DAWN Day One Biopharmaceuticals, Inc.

Fundamentals / CIK 0001845337 / USD

Day One Biopharmaceuticals, Inc. reported $158.2M in revenue and a net loss of $107.3M for the fiscal year ended December 31, 2025 (up 20.6% year over year), with a -80.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DAWN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$175.9M$87.93M$0-$190.1MFY 2019 Net Income: -$12.63M2019FY 2020 Net Income: -$40.51M2020FY 2021 Net Income: -$70.64M2021FY 2022 Revenue: $0FY 2022 Net Income: -$142.2M2022FY 2023 Revenue: $0FY 2023 Net Income: -$188.9M2023FY 2024 Revenue: $131.2MFY 2024 Net Income: -$95.50M2024FY 2025 Revenue: $158.2MFY 2025 Net Income: -$107.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $158.2M $131.2M $0 $0 -- -- --
Research & Development $148.1M $227.7M $130.5M $85.62M $43.58M $9.10M $13.90M
Total Operating Expenses $285.9M $348.4M $206.1M $146.9M $72.74M $13.78M $14.90M
Operating Income -$127.8M -$217.3M -$206.1M -$146.9M -$72.74M -$13.78M -$14.90M
EBITDA -$127.4M -$217.2M -$206.0M -$146.8M -$72.72M -$13.77M -$14.90M
Income Tax Expense -$1.98M $7.14M $0 $0 -- -- --
Net Income -$107.3M -$95.50M -$188.9M -$142.2M -$70.64M -$40.51M -$12.63M
Basic EPS -$1.04 -$1.02 -$2.37 -$2.17 -$4.62 -$7.33 -$2.13
Diluted EPS -$1.04 -$1.02 -$2.37 -$2.17 -$4.62 -$7.33 -$2.13
Basic Shares Outstanding 103.2M 93.2M 79.8M 65.5M 37.0M 5.5M 5.9M
Diluted Shares Outstanding 103.2M 93.2M 79.8M 65.5M 37.0M 5.5M 5.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue $53.72M $39.80M $33.91M $30.76M $29.21M $93.76M $8.19M $0
Research & Development $40.95M $31.42M $36.15M $39.62M $61.82M $33.56M $92.11M $40.21M
Total Operating Expenses $81.18M $64.05M $68.88M $71.83M $94.54M $64.12M $123.0M $66.77M
Operating Income -$27.46M -$24.25M -$34.97M -$41.07M -$65.33M $29.64M -$114.8M -$66.77M
EBITDA -$27.37M -$24.16M -$34.88M -$40.97M -$65.29M $29.65M -$114.8M -$66.74M
Income Tax Expense -$1.98M $0 $0 $0 $6.47M -$882K $1.55M $0
Net Income -$21.28M -$19.73M -$30.32M -$36.00M -$65.71M $37.04M -$4.41M -$62.41M
Basic EPS -- -$0.19 -$0.29 -$0.35 -- $0.38 -$0.05 -$0.72
Diluted EPS -- -$0.19 -$0.29 -$0.35 -- $0.38 -$0.05 -$0.72
Basic Shares Outstanding -- 103.4M 103.1M 102.7M -- 96.6M 87.1M 86.7M
Diluted Shares Outstanding -- 103.4M 103.1M 102.7M -- 96.9M 87.1M 86.7M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $197.1M $125.0M $230.8M $85.26M $284.3M $43.73M
Short-Term Investments $244.0M $406.8M $135.6M $257.0M $0 --
Cash & Short-Term Investments $441.1M $531.7M $366.3M $342.3M $284.3M $43.73M
Accounts Receivable, Net $26.73M $13.88M $0 -- -- --
Inventory $6.33M $3.32M $0 -- -- --
Other Current Assets -- -- -- $347.9M $289.4M $45.07M
Total Current Assets $485.1M $562.3M $375.3M $347.9M $289.4M $45.07M
Property, Plant & Equipment, Net $2.14M $2.29M $208K $20K $57K $77K
Intangible Assets $18.02M $15.63M $0 -- -- --
Total Non-Current Assets $22.73M $20.46M $774K $1.19M $453K $590K
Total Assets $507.8M $582.8M $376.0M $349.1M $289.8M $45.66M
Accounts Payable $3.73M $3.26M $2.58M $260K $1.74M $202K
Deferred Revenue (Current) $2.00M $1.55M $0 -- -- --
Total Current Liabilities $60.52M $73.45M $29.51M $16.61M $8.66M $2.00M
Deferred Revenue (Non-Current) $3.04M $3.23M $0 -- -- --
Other Non-Current Liabilities $484K $761K $0 -- -- --
Total Non-Current Liabilities $6.14M $6.59M $0 $408K $16K $204K
Total Liabilities $66.67M $80.04M $29.51M $17.02M $8.67M $2.20M
Total Debt (incl. Leases) $2.79M $2.60M $408K $813K $220K $402K
Common Stock $10K $10K $9.0K $7.0K $6.0K --
Retained Earnings -$661.4M -$554.1M -$458.6M -$269.7M -$127.5M -$56.84M
Accumulated Other Comp. Income $65K $84K $9.0K -$71K $0 --
Total Stockholders' Equity $441.2M $502.8M $346.5M $332.0M $281.1M -$54.20M
Total Equity $441.2M $502.8M $346.5M $332.0M $281.1M -$54.20M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Cash & Cash Equivalents $197.1M $43.28M $35.62M $33.36M $125.0M $422.8M $239.6M $270.4M
Short-Term Investments $244.0M $408.3M $417.5M $439.7M $406.8M $135.6M $122.2M $47.55M
Cash & Short-Term Investments $441.1M $451.6M $453.1M $473.0M $531.7M $558.4M $361.9M $317.9M
Accounts Receivable, Net $26.73M $16.70M $19.67M $18.05M $13.88M $8.70M $9.14M --
Inventory $6.33M $7.06M $6.54M $3.56M $3.32M $2.73M $151K --
Total Current Assets $485.1M $490.0M $494.4M $508.7M $562.3M $581.0M $383.2M $326.0M
Property, Plant & Equipment, Net $2.14M $2.23M $2.32M $2.51M $2.29M $904K $196K $185K
Intangible Assets $18.02M $18.82M $19.61M $20.41M $15.63M -- -- --
Total Non-Current Assets $22.73M $23.81M $24.61M $25.70M $20.46M $19.81M $17.28M $611K
Total Assets $507.8M $513.8M $519.0M $534.4M $582.8M $600.8M $400.4M $326.6M
Accounts Payable $3.73M $5.78M $5.09M $2.54M $3.26M $3.02M $6.44M $4.78M
Deferred Revenue (Current) $2.00M $2.32M $1.85M $1.64M $1.55M $1.46M -- --
Total Current Liabilities $60.52M $56.47M $51.22M $47.88M $73.45M $39.74M $93.71M $29.84M
Deferred Revenue (Non-Current) $3.04M $2.95M $3.37M $3.35M $3.23M $3.06M -- --
Other Non-Current Liabilities $484K $761K $761K $761K $761K -- -- --
Total Non-Current Liabilities $6.14M $6.45M $6.98M $6.96M $6.59M $5.60M $0 $0
Total Liabilities $66.67M $62.91M $58.20M $54.84M $80.04M $45.34M $93.71M $29.84M
Total Debt (incl. Leases) $2.79M $2.89M $3.00M $2.92M $2.60M $2.62M $190K $300K
Common Stock $10K $10K $10K $10K $10K $10K $9.0K $9.0K
Retained Earnings -$661.4M -$640.1M -$620.4M -$590.1M -$554.1M -$488.4M -$525.4M -$521.0M
Accumulated Other Comp. Income $65K $69K -$92K -$52K $84K -$6.0K -$22K -$5.0K
Total Stockholders' Equity $441.2M $450.9M $460.8M $479.5M $502.8M $555.5M $306.7M $296.8M
Total Equity $441.2M $450.9M $460.8M $479.5M $502.8M $555.5M $306.7M $296.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$107.3M -$95.50M -$188.9M -$142.2M -$72.75M -$43.84M -$16.98M
Depreciation & Amortization $366K $92K $36K $63K $20K $16K $0
Stock-Based Compensation $44.39M $48.26M $39.34M $27.24M $13.32M $526K $111K
Change in Receivables -$12.86M -$13.88M $0 $0 -- -- --
Change in Payables $471K $686K $2.32M -$1.48M $1.54M $132K $14K
Operating Cash Flow -$103.8M -$78.11M -$146.9M -$109.9M -$48.54M -$13.49M -$4.51M
Capital Expenditure -$320K -$2.17M -$224K -$26K $0 -$92K $0
Free Cash Flow -$104.1M -$80.28M -$147.1M -$109.9M -$48.54M -$13.58M -$4.51M
Investing Cash Flow $174.6M -$231.0M $128.4M -$255.1M -$8.00M -$92K $0
Common Stock Issued $0 $0 $161.4M $161.6M $167.0M $0 $0
Financing Cash Flow $1.22M $203.3M $164.0M $165.9M $297.1M $29.98M $30.91M
Net Change in Cash $72.11M -$105.8M $145.5M -$199.0M $240.6M $16.40M $26.39M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Net Income -$21.28M -$19.73M -$30.32M -$36.00M -$65.71M $37.04M -$4.41M -$62.41M
Depreciation & Amortization $91K $90K $91K $94K $38K $16K $15K $23K
Stock-Based Compensation $11.07M $9.56M $10.90M $12.86M $11.04M $11.55M $13.03M $12.64M
Change in Receivables -$10.04M $2.97M -$1.61M -$4.18M -$5.18M $441K -$9.14M $0
Change in Payables -$2.04M $688K $2.55M -$722K $245K -$3.43M $1.66M $2.20M
Operating Cash Flow -$14.15M -$5.80M -$24.81M -$59.00M -$30.01M $50.75M -$49.13M -$49.73M
Capital Expenditure $0 $0 -$3.0K -$317K -$1.42M -$724K -$26K $0
Free Cash Flow -$14.15M -$5.80M -$24.81M -$59.31M -$31.43M $50.03M -$49.16M -$49.73M
Investing Cash Flow $167.5M $13.46M $26.32M -$32.61M -$269.6M -$67.70M $17.06M $89.29M
Financing Cash Flow $471K $0 $748K $0 $1.85M $200.1M $1.30M $48K
Net Change in Cash $153.8M $7.66M $2.26M -$91.61M -$297.8M $183.1M -$30.77M $39.61M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -80.8% -165.7% -- -- -- -- --
Net Profit Margin -67.8% -72.8% -- -- -- -- --
Return on Equity (ROE) -24.3% -19.0% -54.5% -42.8% -25.1% -- --
Return on Assets (ROA) -21.1% -16.4% -50.2% -40.7% -24.4% -88.7% --
Current Ratio 8.02x 7.66x 12.72x 20.94x 33.43x 22.58x --
Quick Ratio 7.91x 7.61x 12.72x 20.60x 32.84x 21.91x --
Debt to Equity 0.01x 0.01x 0.00x 0.00x 0.00x -- --
Revenue Growth (YoY) +20.6% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Operating Margin -80.8% -123.9% -59.5% -118.3% -165.7% -- -- --
Net Profit Margin -67.8% -113.5% -50.6% -42.7% -72.8% -- -- --
Return on Equity (ROE) -24.3% -33.7% -20.6% -14.4% -19.0% -15.2% -54.6% -70.4%
Return on Assets (ROA) -21.1% -29.5% -18.3% -12.9% -16.4% -14.0% -41.8% -64.0%
Current Ratio 8.02x 8.68x 9.65x 10.62x 7.66x 14.62x 4.09x 10.93x
Quick Ratio 7.91x 8.55x 9.53x 10.55x 7.61x 14.55x 4.09x 10.66x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.00x 0.00x 0.00x
Revenue Growth (YoY) +83.9% -57.6% +313.9% -- -- -- -- --
Operating Income Growth (YoY) -- -181.8% -- -- -- -- -- --
Net Income Growth (YoY) -- -153.3% -- -- -- -- -- --
EPS Growth (YoY) -- -150.0% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -111.4% -- -- -- -- -- --
Free Cash Flow Growth (YoY) -- -111.6% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001845337) · from December 31, 2019 Data through December 31, 2025 · synced Nov 20, 2026, 05:22 UTC · Open in terminal